Jump to content

Search the Community

Showing results for tags 'autocontrol'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


  • General Info
    • Question of the Day
    • Introductions
    • Job Postings
    • Off Topic
    • Site Comments / Suggestions
  • BloodBankTalk (USA)
    • Transfusion Services
    • Patient Questions
    • Accrediting Agencies
    • Billing
    • Case Studies
    • Computer Systems / Software / ISBT128
    • Donor Services and Donor Recruitment
    • Education / Quality
    • Equipment
    • Immunohematology Reference Laboratories
    • Tissue, stem cells, and bone marrow
    • Vendor Section
    • All other topics
  • BloodBankTalk (United Kingdom)
    • Haemovigilance
    • Quality
    • UK Guidelines
  • ChemLabTalk
    • General Information
    • Equipment
    • Accrediting Agencies
  • HemeLabTalk
    • General Information
    • Accrediting Agencies
  • MicroLabTalk
    • General Information
    • Quality
  • POCTalk
    • General Information
    • Accrediting Agencies
    • Vendor Selection


  • PathLabTalk News
  • Laboratory News


  • User Submitted
    • Audit checklists
    • Direct Observation Checklists
    • Educational Materials
    • Forms
    • SOPs
  • United States
    • FDA Blood Guidances
    • FDA Memorandum to Blood Establishments
  • Canada
    • Health Canada


  • BloodBankTalk
  • ChemLabTalk
  • HemeLabTalk
  • MicroLabTalk
  • POCTalk
  • General Lab


  • Lab Assistants
  • Medical Laboratory Scientists
  • Research
  • Nursing

Find results in...

Find results that contain...

Date Created

  • Start


Last Updated

  • Start


Filter by number of...


  • Start





Website URL









Real Name

Found 2 results

  1. Does anyone run an autocontrol with the antibody screen if the patient has a history of clinically significant antibodies? We do not normally run an autocontrol with our antibody screens (gel). We run them when we do panel work. I recently ran an autocontrol anticipating a positive screen as the patient already had 3 antibodies, the screen reacted last month, and he had been transfused recently. The screen was negative, the autocontrol was positive, and the eluate was negative. I did go beyond our policy since the screen was negative, but I felt better about issuing the blood, and talked to the supervisor about it. We'd both like to know what the policy is at other places.
  2. For those of you treating cells with DTT for patients taking daratumumab/darzalex: Have you come across a positive autocontrol, with treated and untreated cells? Currently, patient on DARA: initial screen-panagglutinin, auto-positive. Testing with treated cells: screen-negative, auto-positive. QC-valid (testing Kpos and Epos cell) antigen typing for K-neg, E-pos I have been unable to find any research with this information. We are currently in the process of validating DTT treatment. Any advice would be welcomed. Thank you
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.